Trading Statement

Tate & Lyle PLC
                  

25 January 2005 - Tate & Lyle PLC

Trading Update

Tate & Lyle issues the following routine trading update following annual sales
contract pricing rounds at two of its major businesses.

Trading since the announcement of our interim results on 4 November 2004 has
continued to go well and the outlook for the year to 31 March 2005 has not
altered.

Tate & Lyle Food and Industrial Ingredients Americas (formerly Staley) has
substantially completed the negotiation of its calendar 2005 sales contracts.
Overall in calendar 2005 in local currency, and despite higher energy costs, we
expect at least to maintain sweetener total net margins at calendar 2004 levels.
We anticipate achieving higher total net margins on value added food ingredients
and other products.

The 2005 calendar sweetener pricing round for Tate & Lyle Food and Industrial
Ingredients Europe (formerly Amylum) has been competitive. After higher energy
costs we expect total sweetener and starch net margins to be slightly below
those achieved in calendar 2004.

Demand for sucralose remains strong and our expansion projects are on track.

For more information contact Tate & Lyle PLC:

Mark Robinson, Head of Investor Relations Tel: [phone] or Mobile:
[phone] Email: [e-mail]

Chris Fox, Director of Corporate Relations (Press) Tel: [phone] or
Mobile: [phone]

About Tate & Lyle Tate & Lyle is a world leader in renewable ingredients. Its
core competence is to take corn, wheat or sugar, and add value to these raw
materials through technology. As a result of continuous innovation it offers an
ever-wider product portfolio of versatile and functional ingredients. These
products include Cereal Sweeteners, Starches, Sugars, Citric Acid and SPLENDA®
Sucralose. Tate & Lyle products have wide applications in the food, beverage,
pharmaceutical, cosmetic, paper, packaging and building industries.

With headquarters in London, Tate & Lyle operates more than 41 plants and 20
additional production facilities in 28 countries, almost all in Europe and the
Americas. It employs 6,700 people in its subsidiaries with a further 4,800
employed in joint ventures. Sales in the year to 31 March 2004 totalled £3,167
million. More details are available on this website www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC